Arnim Laicher

Title: Arnim Laicher: Innovator in Pharmaceutical Modifications

Introduction

Arnim Laicher is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on Lifibrol. His expertise and dedication to research have led to advancements that benefit the industry.

Latest Patents

Arnim Laicher holds a patent for a new modification of Lifibrol, which is described as having a melting point of 132°C to 138°C, particularly between 134°C and 136°C. This modification is characterized by a primary peak in its IR spectrum at a wave number of 3,200 to 3,400, preferably at 3,250 to 3,350. The new modification, referred to as modification II, is distinguished by its ability to allow for good crystallization. This property enables it to be formulated without issues on a large industrial scale, resulting in tablets that are of acceptable size and high stability.

Career Highlights

Arnim Laicher is currently associated with Klinge Pharma GmbH, where he continues to apply his innovative thinking to pharmaceutical development. His work has been instrumental in enhancing the formulation processes within the company.

Collaborations

Throughout his career, Arnim has collaborated with talented individuals such as Artur Burger and Anita Lettenbichler. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Arnim Laicher's contributions to the field of pharmaceuticals, particularly through his patent on Lifibrol, highlight his role as an innovator. His work not only advances scientific knowledge but also enhances the practical applications of pharmaceutical products.